These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer.
    Author: Bevan S, Edwards SM, Ardern Jones A, Dowe A, Southgate C, Dearnaley D, Easton DF, Houlston RS, Eeles RA, CRC/BPG UK Familial Prostate Cancer Study Collaborators.
    Journal: Prostate Cancer Prostatic Dis; 2003; 6(1):12-4. PubMed ID: 12664059.
    Abstract:
    Inherited susceptibility to prostate cancer has been linked to a number of chromosomal regions, however no genes have been unequivocally shown to underlie reported linkages. The putative gene localised to chromosome 1q42-q43, has been designated PCaP. We have recently shown that germline mutations in the fumarate hydratase (FH) gene located on 1q43 cause smooth muscle tumours and renal cell carcinoma. It is conceivable that germline FH mutations might confer an increased risk of prostate cancer and underlie linkage of prostate cancer to PCaP. To examine this proposition we have analysed the entire coding region of FH in 160 prostate cancer cases in 77 multiple case families. No pathogenic mutations in FH were identified in any of the cases. This data makes it highly unlikely that mutations in FH confer susceptibility to prostate cancer.
    [Abstract] [Full Text] [Related] [New Search]